R-Tech Ueno: Completion of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes
4/24/2012 8:58:00 AM
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) is pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes Note 1. The details are given below.
comments powered by